<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Amoy_Project_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Amoy/Project/Results</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Aomy/Project</TITLE></P><DIV id="menu"><UL id="nav"><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Team" id="products" class="top_link"><SPAN class="down">TEAM</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Team#member_student">Member</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Member/Amoy">Amoy</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Attributions">Attributions</A></LI></UL><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Project" id="products" class="top_link"><SPAN class="down active">PROJECT</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Background">Background</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Description">Description</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Methods">Methods</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Discussion">Discussion</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/FutureWork">Future Work</A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Notebook" id="products" class="top_link"><SPAN class="down">NOTEBOOK</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Notebook/Notebook">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Notebook/Protocol">Protocols</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Notebook/Gallery">Gallery</A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Interlab" id="products" class="top_link"><SPAN class="down">INTERLAB</SPAN></A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Newsletter" id="products" class="top_link"><SPAN class="down">NEWSLETTER</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Newsletter#title">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Newsletter/Contribution">Contribution</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Newsletter/Discussion">Discussion</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Newsletter/Links">Links</A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Practices" id="products" class="top_link"><SPAN class="down">PRACTICES</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Practices/Promotion">Promotion</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Practices/Talk">Talk</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Practice/Communication">Communication</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Collaborations">Collaborations</A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Judging" id="products" class="top_link"><SPAN class="down">JUDGING</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Judging/Medal">Medal Criteria</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Judging/Acknowledgement">Acknowledgement</A></LI><LI class="top"><A href="https://2015.igem.org/Team:Amoy/Safety" id="products" class="top_link"><SPAN class="down">SAFETY</SPAN></A></LI></DIV><DIV id="main_content" style="width: 90%; margin: 0 auto; display: -webkit-box; padding-top: 50px;"><DIV id="s_menu" class="col-md-2" style="z-index: 999;"><A href="https://2015.igem.org/Team:Amoy/Project"><H4>Project</H4></A><UL class="ul_menu"><LI><A href="https://2015.igem.org/Team:Amoy/Project/Background">Background</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Description">Description</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Methods">Methods</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/Discussion">Discussion</A></LI><LI><A href="https://2015.igem.org/Team:Amoy/Project/FutureWork">Future work</A></LI></UL></DIV><DIV id="title" style="width: 70%; margin-left: 25%;"><P id="title_p">RESULTS</P><H1 class="main_h1">Ⅰ. Enzyme and protein assays</H1><H2 class="main_h2">1. IPTG Gradient Induction</H2><P class="main_p">We found that the concentration of IPTG could have an effect on the expression of our circuits, in order to make an better expression of the protein in the cell, we decided to make a IPTG gradient induction for our gene circuits. After measuring the enzyme activity and ran SDS-PAGE, We found the optimal IPTG concentration . As shown in the graph, the enzyme activity data and SDS-PAGE show  the most suitable concentration of the enzyme</P><DIV style="width: 100%; display: block;"><P class="figure" style=" display: inline-block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.1 </STRONG> SDS-PAGE Analysis of cell-free crude extracts LeuDH (34+L) from <I>E.coli</I> BL21. The arrow points to the optimal band of LeuDH</P><P class="figure" style=" display: inline-block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.2 </STRONG> Different concentrations of IPTG on the Enzyme activity of 34+L</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.3 </STRONG>SDS-PAGE Analysis of cell-free crude extracts FDH (34+F) from <I>E.coli</I> BL21. The arrow points to the optimal band of FDH</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.4 </STRONG>Different concentrations of IPTG on the Enzyme activity of 34+F</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.5</STRONG>SDS-PAGE Analysis of cell-free crude extracts LeuDH (30+F) from <I>E.coli</I> BL21. The arrow points to the optimal band of LeuDH</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.6</STRONG> Different concentrations of IPTG on the Enzyme activity of 30+L</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.7</STRONG> SDS-PAGE Analysis of cell-free crude extracts LeuDH (32+F) from <I>E.coli</I> BL21. The arrow points to the band of LeuDH.</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.8</STRONG> Different concentrations of IPTG on the Enzyme activity of 32+L</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.9</STRONG> SDS-PAGE Analysis of cell-free crude extracts LeuDH(30+L) and FDH(34+F) from <I>E.coli</I> BL21. The black arrow points to the optimal band of FDH. The red black arrow points to the optimal band of LeuDH.</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.10</STRONG> Different concentrations of IPTG on the Enzyme activity of 30+L+34+</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.11</STRONG> SDS-PAGE Analysis of cell-free crude extracts LeuDH (34+L)and FDH (34+L)from <I>E.coli</I> BL21. The black arrow points to the optimal band of FDH. The red black arrow points to the optimal band of LeuDH.</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.12</STRONG> Different concentrations of IPTG on the Enzyme activity of 34+L+34+F</P></DIV><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 1.13</STRONG> SDS-PAGE Analysis of cell-free crude extracts LeuDH(32+L) and FDH(34+F) from <I>E.coli</I> BL21. The black arrow points to the optimal band of FDH. The red black arrow points to the optimal band of LeuDH.</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 1.14</STRONG> Different concentrations of IPTG on the Enzyme activity of 32+L+34+F</P></DIV><H2 class="main_h2 col-md-12">2. HPLC</H2><P class="figure" style="display: block; text-align: center;"><STRONG>Figure 2.1</STRONG> The e.e.value of series connection</P><P class="main_p col-md-12">Enantiomeric excess (e.e.) value is a measurement of purity used for chiral substances. It reflects the degree to which a sample contains one enantiomer in greater amounts than the other. A racemic mixture has an e.e. value of 0%, while a single completely pure enantiomer has an e.e. value of 100%. A sample with 70% of one enantiomer and 30% of the other has an ee of 40%. The HPLC results also show the ideal e.e. value of our products. No matter which circuits of our project, the e.e. value all turns to be 99% which means the perfect optical purity of L-<I>tert</I>-leucine.
</P><P class="main_p col-md-12">Under the conditions of optimum concentration, we carried out the next step of catalysis and induction,  Apart from taking all three whole circuits into analysis, we detected circuits with LeuDH or FDH separately.</P><DIV style="width: 100%; display: block;"><P class="figure" style="display: block; width: 48%; float: left; margin-left: 1%;"><STRONG>Figure 2.2</STRONG> The conversion rate of isolated connection</P><P class="figure" style="display: block; width: 48%; float: right; margin-right: 1%;"><STRONG>Figure 2.3</STRONG> The conversion rate of series connection</P></DIV><P class="main_p col-md-12">No matter which kind of RBS, the conversion rate does not show too many changes compared with each other, indicating that RBS control would not make an effect if the whole system is expressed separately. Obviously, the conversion rate of series connected circuits is much higher than the other. As we mentioned on the whole-cell biocatalyst part, our project which make two genes into series connection would largely promote the productivity and conversion rate of L-tert Leucine.we found RBS_B0030 make the best performance among these three kinds of RBSs which indicate that the most suitable strength of RBS is located at this range.</P></DIV></DIV><DIV style="width: 100%; height: 240px; background: #2a2a2a; position: relative; padding-top: 20px;" class="col-md-12"><DIV style="display: inline-block; position: relative; top: 45px; width: 21%; margin-left: 2%;"><P style="font-size: 16px; color: #fff; border-bottom: 1px solid #fff; padding-bottom: 5px; margin-bottom: 0px;">CONTACT US</P><P style="font-size: 14px; color: #fff; margin-top: 5px; margin-bottom: 0px;"><STRONG>Email:  </STRONG>igemxmu@gmail.com</P><P style="font-size: 14px; color: #fff; margin-bottom: 0px;"><STRONG>Website:  </STRONG><A href="https://2015.igem.org/Team:Amoy" target="_blank" style="color: #fff;">2015.igem.org/Team:Amoy</A></P><P style="font-size: 14px; color: #fff; margin-bottom: 0px;"><STRONG>Address:  </STRONG>Xiamen University, No. 422, Siming South Road, Xiamen, Fujian, P.R.China 361005</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>